Oncology information systems is a software that is used to manage extensive cancer patient data and oversee procedures associated with oncology care. The advantages of using oncology information systems such as cost-saving, future-proofing, and environment-friendly, has increased the pressure on healthcare organization to upgrade their procedure from paper-based to paperless systems. The global oncology information systems market was valued at $2,247 million in 2015, and is estimated to reach $3,755 million by 2022, registering a CAGR of 7.5% 2016 to 2022.
The global oncology information systems market is segmented based on products and services, applications, end user, and geography. Based on products and services, it is classified into software and services. Software segment is further bifurcated into patient information systems and treatment planning systems. Services are further segmented into consulting/optimization services, implementation services, and post-sale and maintenance services. Based on applications, it is categorized into radiation, medical, and surgical oncology. Based on end users, it is bifurcated into hospitals and oncology clinics, and research centers. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The market growth is attributed to the surge in prevalence of cancer and technological advancements in oncology information systems, and the increase in disposable income among these patients. The benefits of using oncology information systems over conventional methods of record maintenance and treatment procedures, and rise in the healthcare expenditure are expected to increase the demand for these systems, thus fueling the market growth. However, dearth of healthcare IT professionals and high costs associated with oncology information systems are expected to hamper the growth.
KEY MARKET BENEFITS
This report offers a detailed quantitative analysis of the current market trends from 2014 to 2022 to identify the prevailing opportunities.
The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to products and services, application, end user, and geography.
In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY PLAYERS PROFILED
Accuray Incorporated
Bogardus Medical Systems, Inc.
Cerner Corporation
CureMD Corporation
Elekta AB
Flatiron Health, Inc.
Koninklijke Philips N.V.
McKesson Corporation
RaySearch Laboratories AB
Varian Medical Systems, Inc.
KEY MARKET SEGMENTS
By Products and Services
Software
Patient Information Systems
Treatment Planning Systems
Services
Consulting/Optimization Services
Implementation Services
Post-sale & Maintenance Services
By Application
Radiation Oncology
Medical Oncology
Surgical Oncology
By End User
Hospitals and Oncology Clinics
Research Centers
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Republic of South Africa
Saudi Arabia
Rest of LAMEA
The other players of the catheters market include (companies not profiled in the report):
IMPAC Medical Systems, Inc.
Siemens Healthcare
Epic Systems Corporation
Bizmatics, Inc.
Charm Health
Cordata Healthcare Innovations, LLC.
